Publications

1. Falloon K, Dossaji Z, Mude P, Abushamma S, Ananthakrishnan A, Barnes EL, Bhalla J, Bhattacharya A, Cheemalavagu S, Colombel JF, Cross RK, Ermann J, Ha C, Herfarth H, Horst S, Hou J, Husni ME, Kline TM, Kuhn KA, Long MD, Loftus EV Jr, Lukin DJ, Patel A, Rubin DT, Scherl EJ, Shah SA, Siaton BC, Sleiman J, Qazi T, Weisman MH, Cohen BL, Feagan BG, Rieder F. Diagnosis of Inflammatory Bowel Disease-Associated Peripheral Arthritis: A Systematic Review. Inflamm Bowel Dis. 2024 Jun 5 Epub 2024 June 05
   View PubMed
2. Bettenworth D, Baker ME, Fletcher JG, Jairath V, Lu C, Bemelman W, d'Haens G, d'Hoore A, Dignass A, Dotan I, Feakins R, Fleshner P, Ha C, Henderson G, Lyu R, Panes J, Rogler G, Mao R, Rimola J, Sandborn WJ, Ng SC, Siegmund B, Silverberg M, Taylor SA, Verstockt B, Gordon IO, Bruining DH, Feagan BG, Rieder F, Stenosis Therapy Anti-Fibrotic Research (STAR) Consortium. A global consensus on the definitions, diagnosis and management of fibrostenosing small bowel Crohn's disease in clinical practice. Nat Rev Gastroenterol Hepatol. 2024 Jun 3 Epub 2024 June 03
   View PubMed
3. Khrom M, Long M, Dube S, Robbins L, Botwin GJ, Yang S, Mengesha E, Li D, Naito T, Bonthala NN, Ha C, Melmed G, Rabizadeh S, Syal G, Vasiliauskas E, Ziring D, Brant SR, Cho J, Duerr RH, Rioux J, Schumm P, Silverberg M, Ananthakrishnan AN, Faubion WA, Jabri B, Lira SA, Newberry RD, Sandler RS, Xavier RJ, Kugathasan S, Hercules D, Targan SR, Sartor RB, Haritunians T, McGovern DPB. Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease. Gastroenterology. 2024 Mar 13 [Epub ahead of print]
   View PubMed
4. Elmasry S, Ha C. Evidence-Based Approach to the Management of Mild Crohn's Disease. Clin Gastroenterol Hepatol. 2024 Mar; 22 (3):480-483 Epub 2023 Dec 20
   View PubMed
5. Akhlaghpour M, Haritunians T, More SK, Thomas LS, Stamps DT, Dube S, Li D, Yang S, Landers CJ, Mengesha E, Hamade H, Murali R, Potdar AA, Wolf AJ, Botwin GJ, Khrom M, Ananthakrishnan AN, Faubion WA, Jabri B, Lira SA, Newberry RD, Sandler RS, Sartor RB, Xavier RJ, Brant SR, Cho JH, Duerr RH, Lazarev MG, Rioux JD, Schumm LP, Silverberg MS, Zaghiyan K, Fleshner P, Melmed GY, Vasiliauskas EA, Ha C, Rabizadeh S, Syal G, Bonthala NN, Ziring DA, Targan SR, Long MD, McGovern DPB, Michelsen KS, International IBD Genetics Consortium. Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis. Gut. 2023 Nov; 72 (11):2068-2080 Epub 2023 Apr 20
   View PubMed
6. Chiorean M, Ha C, Hur P, Sharma PP, Gruben D, Khan NH. Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database. Dig Dis Sci. 2023 Oct; 68 (10):3985-3993 Epub 2023 Aug 28
   View PubMed
7. Singh S, Kim J, Luo J, Paul P, Rudrapatna V, Park S, Zheng K, Syal G, Ha C, Fleshner P, McGovern D, Sauk JS, Limketkai B, Dulai PS, Boland BS, Eisenstein S, Ramamoorthy S, Melmed G, Mahadevan U, Sandborn WJ, Ohno-Machado L. Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort Study. Clin Gastroenterol Hepatol. 2023 Aug; 21 (9):2359-2369.e5 Epub 2022 Nov 05
   View PubMed
8. Chase RC, Tamim H, Sheikh WGE, Clift K, Bruining D, Ha C, Farraye FA, Hashash JG. Association of serum IgG4 and disease outcomes in patients with inflammatory bowel disease. Ann Gastroenterol. 2023 Jul-Aug; 36 (4):423-429 Epub 2023 May 29
   View PubMed
9. Nguyen NH, Luo J, Paul P, Kim J, Syal G, Ha C, Rudrapatna V, Park S, Parekh N, Zheng K, Sauk JS, Limketkai B, Fleshner P, Eisenstein S, Ramamoorthy S, Melmed G, Dulai PS, Boland BS, Mahadevan U, Sandborn WJ, Ohno-Machado L, McGovern D, Singh S. Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study. Clin Gastroenterol Hepatol. 2023 Jan; 21 (1):173-181.e5 Epub 2022 May 27
   View PubMed
10. Gu P, Luo J, Kim J, Paul P, Limketkai B, Sauk JS, Park S, Parekh N, Zheng K, Rudrapatna V, Syal G, Ha C, McGovern DP, Melmed GY, Fleshner P, Eisenstein S, Ramamoorthy S, Dulai PS, Boland BS, Grunvald E, Mahadevan U, Ohno-Machado L, Sandborn WJ, Singh S. Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study. Am J Gastroenterol. 2022 Oct 1; 117 (10):1639-1647 Epub 2022 June 07
    View PubMed
11. Almario CV, van Deen WK, Chen M, Gale R, Sidorkiewicz S, Choi SY, Bonthala N, Ha C, Syal G, Dupuy T, Liu X, Melmed GY, Spiegel BMR. Interactive Inflammatory Bowel Disease Biologics Decision Aid Does Not Improve Patient Outcomes Over Static Education: Results From a Randomized Trial. Am J Gastroenterol. 2022 Sep 1; 117 (9):1508-1518 Epub 2022 June 10
    View PubMed
12. Falloon K, Cohen B, Ananthakrishnan AN, Barnes EL, Bhattacharya A, Colombel JF, Cross RK, Driscoll MS, Fernandez AP, Ha C, Herfarth H, Horst S, Hou J, Husni ME, Kroshinsky D, Kuhn KA, Lowder CY, Martin G, Parikh D, Sayed CJ, Schocket L, Siaton BC, Vedak P, Weisman MH, Rieder F. A United States expert consensus to standardise definitions, follow-up, and treatment targets for extra-intestinal manifestations in inflammatory bowel disease. Aliment Pharmacol Ther. 2022 May; 55 (9):1179-1191 Epub 2022 Mar 11
    View PubMed
13. Kushner T, Fairchild A, Johnson FR, Sands BE, Mahadevan U, Subramanian S, Ananthakrishnan A, Ha C, Bewtra M. Women's Willingness to Accept Risks of Medication for Inflammatory Bowel Disease During Pregnancy. Patient. 2022 May; 15 (3):353-365 Epub 2021 Nov 09
    View PubMed
14. Dasharathy SS, Long MD, Lackner JM, Ben-Ami Shor D, Yang L, Bar N, Ha C, Weiss GA. Psychological Factors Associated With Adherence to Oral Treatment in Ulcerative Colitis. Inflamm Bowel Dis. 2022 Mar 24 [Epub ahead of print]
    View PubMed
15. Pozdnyakova V, Botwin GJ, Sobhani K, Prostko J, Braun J, Mcgovern DPB, Melmed GY, Appel K, Banty A, Feldman E, Ha C, Kumar R, Lee S, Rabizadeh S, Stein T, Syal G, Targan S, Vasiliauskas E, Ziring D, Debbas P, Hampton M, Mengesha E, Stewart JL, Frias EC, Cheng S, Ebinger J, Figueiredo JC, Boland B, Charabaty A, Chiorean M, Cohen E, Flynn A, Valentine J, Fudman D, Horizon A, Hou J, Hwang C, Lazarev M, Lum D, Fausel R, Reddy S, Mattar M, Metwally M, Ostrov A, Parekh N, Raffals L, Sheibani S, Siegel C, Wolf D, Younes Z. Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients With Inflammatory Bowel Disease. Gastroenterology. 2021 Dec; 161 (6):2041-2043.e1 Epub 2021 Aug 12
    View PubMed
16. Fenster M, Alayo QA, Khatiwada A, Wang W, Dimopoulos C, Gutierrez A, Ciorba MA, Christophi GP, Hirten RP, Ha C, Beniwal-Patel P, Cohen BL, Syal G, Yarur A, Patel A, Colombel JF, Pekow J, Ungaro RC, Rubin DT, Deepak P. Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC Consortium. Clin Gastroenterol Hepatol. 2021 Oct; 19 (10):2207-2209.e3 Epub 2020 Oct 14
    View PubMed
17. Parrish AB, Lopez NE, Truong A, Zaghiyan K, Melmed GY, McGovern DPB, Ha C, Syal G, Bonthala N, Jain A, Landers CJ, Targan SR, Fleshner P. Preoperative Serum Vedolizumab Levels Do Not Impact Postoperative Outcomes in Inflammatory Bowel Disease. Dis Colon Rectum. 2021 Oct 1; 64 (10):1259-1266
    View PubMed
18. Rabinowitz LG, Grinspan LT, Zylberberg HM, Dixon R, David YN, Aroniadis OC, Chiang A, Christie J, Fayad NF, Ha C, Harris LA, Ko CW, Kolb J, Kwah J, Lee L, Lieberman D, Raffals LE, Rex DK, Shah SC, Siddiqui UD, Smith MS, Wallace M, Williams R, Woods K, Crowe SE, Kumta NA, Kim MK, Greenwald DA. Survey Finds Gender Disparities Impact Both Women Mentors and Mentees in Gastroenterology. Am J Gastroenterol. 2021 Sep 1; 116 (9):1876-1884
    View PubMed
19. Truong A, Zaghiyan KN, Mirocha J, Melmed GY, McGovern DPB, Syal G, Ha CY, Targan SR, Fleshner PR. Antitumour necrosis factor therapy is associated with de novo Crohn's disease after ileal pouch-anal anastomosis. Colorectal Dis. 2021 Sep; 23 (9):2416-2424 Epub 2021 July 16
    View PubMed
20. Deepak P, Alayo QA, Khatiwada A, Lin B, Fenster M, Dimopoulos C, Bader G, Weisshof R, Jacobs M, Gutierrez A, Ciorba MA, Christophi GP, Patel A, Hirten RP, Colombel JF, Rubin DT, Ha C, Beniwal-Patel P, Ungaro RC, Syal G, Pekow J, Cohen BL, Yarur A. Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol. 2021 Aug; 19 (8):1592-1601.e3 Epub 2020 July 03
    View PubMed
21. Syal G, Shemtov R, Bonthala N, Vasiliauskas EA, Feldman EJ, Zaghiyan K, Ha CY, McGovern DPB, Targan SR, Melmed GY, Fleshner PR. Pre-pouch Ileitis is Associated with Development of Crohn's Disease-like Complications and Pouch Failure. J Crohns Colitis. 2021 Jun 22; 15 (6):960-968
    View PubMed
22. Sands BE, Colombel JF, Ha C, Farnier M, Armuzzi A, Quirk D, Friedman GS, Kwok K, Salese L, Su C, Taub PR. Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient Management. Inflamm Bowel Dis. 2021 May 17; 27 (6):797-808
    View PubMed
23. Syal G, Robbins L, Kashani A, Bonthala N, Feldman E, Fleshner P, Vasiliauskas E, McGovern D, Ha C, Targan S, Melmed GY. Hypoalbuminemia and Bandemia Predict Failure of Infliximab Rescue Therapy in Acute Severe Ulcerative Colitis. Dig Dis Sci. 2021 Jan; 66 (1):199-205 Epub 2020 Mar 13
    View PubMed
24. Du L, Ha C. Epidemiology and Pathogenesis of Ulcerative Colitis. Gastroenterol Clin North Am. 2020 Dec; 49 (4):643-654 Epub 2020 Sept 25
    View PubMed
25. Cohen BL, Gallinger ZR, Ha C, Holubar SD, Hou JK, Kinnucan J, Mahadevan U, Moss AC, Raffals LE, Regueiro M, Szigethy E, Wolf D, Dubinsky MC, Patel A, Shah BJ, Ehrlich OG, Hanauer SB. Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States. Inflamm Bowel Dis. 2020 Aug 20; 26 (9):1291-1305
    View PubMed
26. Bajaj JS, Brenner DM, Cai Q, Cash BD, Crowell M, DiBaise J, Gallegos-Orozco JF, Gardner TB, Gyawali CP, Ha C, Holtmann G, Jamil LH, Kaplan GG, Karsan HA, Kinoshita Y, Lebwohl B, Leontiadis GI, Lichtenstein GR, Longstreth GF, Muthusamy VR, Oxentenko AS, Pimentel M, Pisegna JR, Rubenstein JH, Russo MW, Saini SD, Samadder NJ, Shaukat A, Simren M, Stevens T, Valdovinos M, Vargas H, Spiegel B, Lacy BE. Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology. Am J Gastroenterol. 2020 Jul; 115 (7):1007-1018
    View PubMed
27. Cohen ER, Salem M, Ha C. Managing Immunosuppressed Patients With Inflammatory Bowel Disease During a Measles Outbreak. Am J Gastroenterol. 2019 Oct; 114 (10):1563-1565
    View PubMed
28. Scott FI, Rubin DT, Kugathasan S, Bousvaros A, Elson CO, Newberry RD, Melmed GY, Pekow J, Fleshman JW, Boyle BM, Mahadevan U, Cannon LM, Long MD, Cross RK, Ha CY, Lasch KL, Robinson AM, Rafferty JF, Lee JJ, Dahl KDC, Weaver A, Shtraizent N, Honig G, Hurtado-Lorenzo A, Heller CA. Challenges in IBD Research: Pragmatic Clinical Research. Inflamm Bowel Dis. 2019 May 16; 25 (Suppl 2):S40-S47
    View PubMed
29. Weber AT, Ather N, Tran V, Sauk J, Ha C. Higher sedation requirements among inflammatory bowel disease patients undergoing colonoscopy for disease activity assessment or dysplasia surveillance Crohns Colitis 360. 2019; 1(1).
    
30. Russell TA, Dawes AJ, Graham DS, Angarita SAK, Ha C, Sack J. Rescue Diverting Loop Ileostomy: An Alternative to Emergent Colectomy in the Setting of Severe Acute Refractory IBD-Colitis. Dis Colon Rectum. 2018 Feb; 61 (2):214-220
    View PubMed
31. Tran V, Phan J, Nulsen B, Huang L, Kaneshiro M, Weiss G, Ho W, Sack J, Ha C, Uslan D, Sauk JS. Severe Ileocolonic Crohn's Disease Flare Associated with Fecal Microbiota Transplantation Requiring Diverting Ileostomy. ACG Case Rep J. 2018; 5:e97 Epub 2018 Dec 19
    View PubMed
32. Eluri S, Parian AM, Limketkai BN, Ha CY, Brant SR, Dudley-Brown S, Efron JE, Fang SG, Gearhart SL, Marohn MR, Meltzer SJ, Bashar S, Truta B, Montgomery EA, Lazarev MG. Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2017 Dec; 62(12):3586-3593. Epub 2017 Jun 19.
    View PubMed
33. Tran DH, Wang J, Ha C, Ho W, Mattai SA, Oikonomopoulos A, Weiss G, Lacey P, Cheng M, Shieh C, Mussatto CC, Ho S, Hommes D, Koon HW. Circulating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohn's disease, and clinical prognosis in inflammatory bowel disease. BMC Gastroenterol. 2017 May 12; 17 (1):63
    View PubMed
34. Van Deen WK, van der Meulen-de Jong AE, Parekh NK, Kane E, Zand A, DiNicola CA, Hall L, Inserra EK, Choi JM, Ha CY, Esrailian E, van Oijen MG, Hommes DW. Development and Validation of an Inflammatory Bowel Diseases Monitoring Index for Use With Mobile Health Technologies. Clin Gastroenterol Hepatol. 2016 Dec; 14 (12):1742-1750.e7 Epub 2015 Nov 18
    View PubMed
35. Ha CY, Kornbluth A. A Critical Review of Biosimilars in IBD: The Confluence of Biologic Drug Development, Regulatory Requirements, Clinical Outcomes, and Big Business. Inflamm Bowel Dis. 2016 Oct; 22 (10):2513-26
    View PubMed
36. Cohen BL, Ha C, Ananthakrishnan AN, Rieder F, Bewtra M. State of Adult Trainee Inflammatory Bowel Disease Education in the United States: A National Survey. Inflamm Bowel Dis. 2016 Jul; 22 (7):1609-15
    View PubMed
37. Parian A, Koh J, Limketkai BN, Eluri S, Rubin DT, Brant SR, Ha CY, Bayless TM, Giardiello F, Hart J, Montgomery E, Lazarev MG. Association between serrated epithelial changes and colorectal dysplasia in inflammatory bowel disease. Gastrointest Endosc. 2016 Jul; 84(1):87-95.e1. Epub 2015 Dec 18.
    View PubMed
38. Geisz M, Ha C, Kappelman MD, Martin CF, Chen W, Anton K, Sandler RS, Long MD. Medication Utilization and the Impact of Continued Corticosteroid Use on Patient-reported Outcomes in Older Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016 Jun; 22 (6):1435-41
    View PubMed
39. Rieder F, Cohen BL, Dotson JL, Bewtra M, Ananthakrishnan AN, Falaiye TO, Ha CY. Rising Educators, Academicians, and Clinicians Helping Inflammatory Bowel Disease (REACH-IBD)-Promoting Improvement of Inflammatory Bowel Disease Education in the United States. Inflamm Bowel Dis. 2016 Jun; 22 (6):1531-2
    View PubMed
40. Zand A, van Deen WK, Inserra EK, Hall L, Kane E, Centeno A, Choi JM, Ha CY, Esrailian E, D'Haens GR, Hommes DW. Presenteeism in Inflammatory Bowel Diseases: A Hidden Problem with Significant Economic Impact. Inflamm Bowel Dis. 2015 Jul; 21 (7):1623-30
    View PubMed
41. Parian A, Ha CY. Older age and steroid use are associated with increasing polypharmacy and potential medication interactions among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015 Jun; 21 (6):1392-400
    View PubMed
42. Ha C, Mathur J, Kornbluth A. Anti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2015 Apr; 9 (4):497-505 Epub 2015 Jan 20
    View PubMed
43. Bennett JL, Ha CY, Efron JE, Gearhart SL, Lazarev MG, Wick EC. Optimizing perioperative Crohn's disease management: role of coordinated medical and surgical care. World J Gastroenterol. 2015 Jan 28; 21 (4):1182-8
    View PubMed
44. Hicks CW, Wick EC, Salvatori R, Ha CY. Perioperative corticosteroid management for patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015 Jan; 21 (1):221-8
    View PubMed
45. Ha C, Kornbluth A. Vedolizumab as a Treatment for Crohn's Disease and Ulcerative Colitis. Gastroenterol Hepatol (N Y). 2014 Dec; 10 (12):793-800
    View PubMed
46. van Deen WK, van Oijen MG, Myers KD, Centeno A, Howard W, Choi JM, Roth BE, McLaughlin EM, Hollander D, Wong-Swanson B, Sack J, Ong MK, Ha CY, Esrailian E, Hommes DW. A nationwide 2010-2012 analysis of U.S. health care utilization in inflammatory bowel diseases. Inflamm Bowel Dis. 2014 Oct; 20 (10):1747-53
    View PubMed
47. Ha CY. Risks of Infection among the Older Inflammatory Bowel Disease Patients. Curr Treat Options Gastroenterol. 2014 Sep; 12 (3):283-91
    View PubMed
48. Lamore RF 3rd, Hechenbleikner EM, Ha C, Salvatori R, Harris LH, Marohn MR, Gearhart SL, Efron JE, Wick EC. Perioperative glucocorticoid prescribing habits in patients with inflammatory bowel disease: a call for standardization. JAMA Surg. 2014 May; 149 (5):459-66
    View PubMed
49. Ha CY, Katz S. Clinical implications of ageing for the management of IBD. Nat Rev Gastroenterol Hepatol. 2014 Feb; 11 (2):128-38 Epub 2013 Dec 17
    View PubMed
50. Ha CY. Medical management of inflammatory bowel disease in the elderly: balancing safety and efficacy. Clin Geriatr Med. 2014 Feb; 30 (1):67-78
    View PubMed
51. Ha C, Katz S. Management of inflammatory bowel disease in the elderly: do biologicals offer a better alternative? Drugs Aging. 2013 Nov; 30 (11):871-6
    View PubMed
52. Bafford AC, Powers S, Ha C, Kruse D, Gorfine SR, Chessin DB, Bauer JJ. Immunosuppressive therapy does not increase operative morbidity in patients with Crohn's disease. J Clin Gastroenterol. 2013 Jul; 47 (6):491-5
    View PubMed
53. Ha C, Maser EA, Kornbluth A. Clinical presentation and outcomes of inflammatory bowel disease patients admitted to the intensive care unit. J Clin Gastroenterol. 2013 Jul; 47 (6):485-90
    View PubMed
54. Ha C, Katz S. Elderly-onset IBD: a milder disease? Nat Rev Gastroenterol Hepatol. 2013 May; 10 (5):264-5 Epub 2013 Apr 02
    View PubMed
55. Ha CY, Katz S. Clinical outcomes and management of inflammatory bowel disease in the older patient. Curr Gastroenterol Rep. 2013 Feb; 15 (2):310
    View PubMed
56. Ha CY. Diagnosis and treatment of inflammatory bowel disease in older patients. Gastroenterol Hepatol (N Y). 2012 Oct; 8 (10):669-70
    View PubMed
57. Ha C, Ullman TA, Siegel CA, Kornbluth A. Patients enrolled in randomized controlled trials do not represent the inflammatory bowel disease patient population. Clin Gastroenterol Hepatol 2012 Sep; 10 (9):1002-7; quiz e78 Epub 2012 Feb 15
    View PubMed
58. Bafford AC, Coakley B, Powers S, Greenwald D, Ha CY, Weintraub J, Chessin DB, Gorfine SR, Bauer JJ. The clinical impact of preoperative percutaneous drainage of abdominopelvic abscesses in patients with Crohn's disease. Int J Colorectal Dis. 2012 Jul; 27 (7):953-8 Epub 2012 Jan 17
    View PubMed
59. Ha CY, Kumar N, Raptis CA, Narra VR, Ciorba MA. Magnetic resonance enterography: safe and effective imaging for stricturing Crohn's disease. Dig Dis Sci. 2011 Oct; 56 (10):2906-13 Epub 2011 June 19
    View PubMed
60. Ha C, Kornbluth A. Mucosal healing in inflammatory bowel disease: where do we stand? Curr Gastroenterol Rep. 2010 Dec; 12 (6):471-8
    View PubMed
61. Ha C, Dassopoulos T. Thiopurine therapy in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2010 Oct; 4 (5):575-88
    View PubMed
62. Early DS, Gao F, Ha CY, Nagler A, Cole E, Gorbe E, Napoli N, Armamento-Villareal R. The association between a functional CYP1A1 polymorphism and colorectal neoplasia risk in post menopausal women. Dig Dis Sci. 2010 Oct; 55 (10):2965-70 Epub 2010 Jan 22
    View PubMed
63. Williams MD, Ha CY, Ciorba MA. Probiotics as therapy in gastroenterology: a study of physician opinions and recommendations. J Clin Gastroenterol. 2010 Oct; 44 (9):631-6
    View PubMed
64. Ha CY, Newberry RD, Stone CD, Ciorba MA. Patients with late-adult-onset ulcerative colitis have better outcomes than those with early onset disease. Clin Gastroenterol Hepatol. 2010 Aug; 8 (8):682-687.e1 Epub 2010 Apr 02
    View PubMed
65. Ha C, Magowan S, Accortt NA, Chen J, Stone CD. Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol. 2009 Jun; 104 (6):1445-51 Epub 2009 Apr 21
    View PubMed
66. Ha CY, Shah R, Chen J, Azar RR, Edmundowicz SA, Early DS. Diagnosis and management of GI stromal tumors by EUS-FNA: a survey of opinions and practices of endosonographers. Gastrointest Endosc. 2009 May; 69 (6):1039-44.e1
    View PubMed
67. Lin AW, Gonzalez SA, Cunningham-Rundles S, Dorante G, Marshall S, Tignor A, Ha C, Jacobson IM, Talal AH. CD56(+dim) and CD56(+bright) cell activation and apoptosis in hepatitis C virus infection. Clin Exp Immunol. 2004 Aug; 137 (2):408-16
    View PubMed
68. Sesso HD, Paffenbarger RS, Ha T, Lee IM. Physical activity and cardiovascular disease risk in middle-aged and older women. Am J Epidemiol. 1999 Aug 15; 150 (4):408-16
    View PubMed